classifAI

Imaging Technologies for Sample Analysis

Health Tech & Life Sciences
Non Active, Jun 2020 ceased to operate
Follow

Company Overview

Snapshot

Founded in February 2020 by Benjamin Sinvani, Teddy Cohen, and Israel Green, classifAI operates with 1–10 employees. The company focuses on imaging technologies for sample analysis, and in June 2020, it ceased operations.

Business overview

classifAI develops advanced AI, deep learning, and big data imaging technologies to rapidly analyze findings in various samples. Its core technology combines high-level photography with AI to identify microorganism behavior patterns, detect material presence or absence, and continuously learn for future testing. The company's solutions enable high-speed identification of food-borne bacteria, early detection of diseases, real-time alerts for food sample issues, and quick detection of precious metals within compounds. classifAI primarily serves the Health Tech & Life Sciences sector, with applications in digital healthcare and laboratories, operating on B2B and B2G business models.

Log in to access full profile

Company Intelligence Q&A

What is classifAI's primary focus?
classifAI specializes in developing AI, deep learning, and big data imaging technologies designed for rapid and accurate analysis of various samples.
When was classifAI founded and by whom?
classifAI was founded in February 2020 by Benjamin Sinvani, Teddy Cohen, and Israel Green.
What markets does classifAI target?
classifAI targets the Health Tech & Life Sciences sector, with specific applications in digital healthcare and laboratories, utilizing B2B and B2G business models.
What are some key applications of classifAI's technology?
The company's technology enables high-speed identification of food-borne bacteria, early detection of diseases and medical conditions, real-time alerts for food sample problems, and rapid detection of precious metals within metal compounds.
What is the operational status of classifAI?
classifAI is currently non-active, having ceased operations in June 2020.
Log in to access full profile